All News
Do Stressed Out Surgeons Have Better or Worse Patient Outcomes?
(MedPage Today) -- Surgeons with higher physiological stress in the first 5 minutes of surgery had fewer major surgical complications, a post-hoc analysis of a prospective study found.
Read MoreSurvival Benefit With Adjuvant T-DM1 in High-Risk HER2-Positive Breast Cancer
(MedPage Today) -- Women with high-risk HER2-positive breast cancer lived significantly longer with adjuvant trastuzumab emtansine (T-DM1, Kadcyla), according to long-term follow-up of a large clinic
Read MoreSTAT+: Jiangsu Hengrui, a preferred China partner for U.S. biotech, hints at more deals
One of the U.S. biotech industry’s preferred partners in China, Jiangsu Hengrui, emphasized its global ambitions and plans for more dealmaking at #JPM25.
Read MoreAspirin Fails to Boost Survival in Colorectal Cancer Trial
(MedPage Today) -- Treating patients with aspirin after completion of standard adjuvant therapy for colorectal cancer failed to significantly improve disease-free survival (DFS) and overall survival,
Read MoreFDA Authorizes Marketing of Nicotine Pouches, a First for the Agency
(MedPage Today) -- The FDA authorized the marketing of 20 different Zyn nicotine pouch products -- the first brand to clear this regulatory hurdle in the increasingly popular class of single-use sa
Read MoreDrug Used in Executions Under Trump May Cause 'Unnecessary' Suffering, DOJ Says
(MedPage Today) -- The Justice Department is rescinding its protocol for federal executions that allowed for single-drug lethal injections with pentobarbital, after a government review raised concern
Read MoreSTAT+: From FDA to JPM, MAHA is top of mind
The CEOs of Eli Lilly and Pfizer weigh in on Trump, the FDA takes action on cigarettes and food dye, and more health care politics and policy news.
Read MorePoor Air Quality PSA; In Defense of Doctors Who Google; Age-Defying Diagnoses
(MedPage Today) -- The following contains links to social media websites including Bluesky, X, TikTok, Instagram, Facebook, and LinkedIn.
Read MoreAmid H5N1, CDC Wants Faster Influenza A Subtyping for Hospitalized Cases
(MedPage Today) -- The CDC is now calling for subtyping of influenza A viruses in all hospitalized patients -- and on an accelerated timeline, ideally within 24 hours.
Read MoreOmvoh Approved for Crohn's; Fitbit Predicts IBD Flares; H. Pylori and Gastric Cancer
(MedPage Today) -- The FDA expanded the approval of mirikizumab (Omvoh) to include treatment of adults with moderately to severely active Crohn's disease, drugmaker Eli Lilly announced; the first-in-
Read More